Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes
F Gustafsson, JG Rogers - European journal of heart failure, 2017 - Wiley Online Library
Despite improvements in pharmacological therapy and pacing, prognosis in advanced heart
failure (HF) remains poor, with a 1‐year mortality of 25–50%. While heart transplantation …
failure (HF) remains poor, with a 1‐year mortality of 25–50%. While heart transplantation …
Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta‐analysis of observational studies
Right ventricular failure (RVF) after left ventricular assist device (LVAD) implantation is
associated with increased morbidity and mortality, but the identification of LVAD candidates …
associated with increased morbidity and mortality, but the identification of LVAD candidates …
2019 EACTS Expert Consensus on long-term mechanical circulatory support
Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …
patients with severe heart failure. Different devices are available, and many—sometimes …
Right ventricular failure after left ventricular assist devices
BC Lampert, JJ Teuteberg - The Journal of Heart and Lung Transplantation, 2015 - Elsevier
Most patients with advanced systolic dysfunction who are assessed for a left ventricular
assist device (LVAD) also have some degree of right ventricular (RV) dysfunction. Hence …
assist device (LVAD) also have some degree of right ventricular (RV) dysfunction. Hence …
Pulmonary artery pulsatility index is associated with right ventricular failure after left ventricular assist device surgery
KJ Morine, MS Kiernan, DT Pham, V Paruchuri… - Journal of cardiac …, 2016 - Elsevier
Background Right ventricular failure (RVF) is a major cause of morbidity and mortality after
CF-LVAD implantation. We explored the association of pulmonary artery compliance (PAC) …
CF-LVAD implantation. We explored the association of pulmonary artery compliance (PAC) …
Patient selection for ventricular assist devices: a moving target
LW Miller, M Guglin - Journal of the American College of Cardiology, 2013 - jacc.org
The number of patients with advanced heart failure that has become unresponsive to
conventional medical therapy is increasing rapidly. One of the most promising new …
conventional medical therapy is increasing rapidly. One of the most promising new …
Inhaled epoprostenol compared with nitric oxide for right ventricular support after major cardiac surgery
BACKGROUND: Right ventricular failure (RVF) is a leading driver of morbidity and death
after major cardiac surgery for advanced heart failure, including orthotopic heart …
after major cardiac surgery for advanced heart failure, including orthotopic heart …
[HTML][HTML] Contemporary outcomes of continuous-flow left ventricular assist devices—a systematic review
N McNamara, H Narroway, M Williams… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background End stage heart failure is a major cause of morbidity and mortality, and its
prevalence is expected to rise with the ageing population. For suitable patients, orthotopic …
prevalence is expected to rise with the ageing population. For suitable patients, orthotopic …
Right ventricular failure after LVAD implantation: prevention and treatment
M Meineri, AE Van Rensburg, A Vegas - Best practice & research Clinical …, 2012 - Elsevier
Right ventricular failure (RVF) complicates 20–50% of left ventricular assist device (LVAD)
implantation cases and contributes to increased postoperative morbidity and mortality …
implantation cases and contributes to increased postoperative morbidity and mortality …
The results of a single-center experience with HeartMate 3 in a biventricular configuration
BACKGROUND Right ventricular (RV) failure after left ventricular assist device (VAD)
implantation is a difficult problem. One solution is the implantation of continuous-flow VADs …
implantation is a difficult problem. One solution is the implantation of continuous-flow VADs …